Clinical Trial Update: A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing low dose versus standard dose ticagrelor on platelet function in acute coronary syndrome patients with diabetes after PCI is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Shanghai Tong Ren Hospital | Conditions: Acute Coronary Syndrome Patients With Diabetes After PCI | Phase 4 | Status: RECRUITING